Leeward Investments, LLC Ma Laboratory Corp Of America Holdings Transaction History

Leeward Investments, LLC Ma

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$209.01 - $232.56 $762,886 - $848,844	3,650 Added 4.97%	77,106 $16.8 Million
Q4 2023 Feb 02, 2024	SELL	$197.69 - $227.29 $388,856 - $447,079	-1,967 Reduced 2.61%	73,456 $16.7 Million
Q3 2023 Oct 10, 2023	BUY	$201.05 - $221.7 $5.06 Million - $5.58 Million	25,159 Added 50.05%	75,423 $15.2 Million
Q2 2023 Jul 26, 2023	SELL	$211.93 - $241.33 $681,990 - $776,599	-3,218 Reduced 6.02%	50,264 $12.1 Million
Q1 2023 Apr 19, 2023	SELL	$213.32 - $257.83 $3.67 Million - $4.43 Million	-17,193 Reduced 24.33%	53,482 $12.3 Million
Q4 2022 Feb 02, 2023	BUY	$203.72 - $248.97 $1.92 Million - $2.35 Million	9,443 Added 15.42%	70,675 $16.6 Million
Q3 2022 Oct 24, 2022	BUY	$204.81 - $262.19 $2.08 Million - $2.67 Million	10,172 Added 19.92%	61,232 $12.5 Million
Q2 2022 Jul 19, 2022	BUY	$213.86 - $277.87 $10.9 Million - $14.2 Million	51,060 New	51,060 $12 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Leeward Investments, LLC Ma, based on Form 13F filings with the SEC.

Stay updated on Leeward Investments, LLC Ma with notifications on news.